» Articles » PMID: 10590330

Protection Against Diverse Highly Pathogenic H5 Avian Influenza Viruses in Chickens Immunized with a Recombinant Fowlpox Vaccine Containing an H5 Avian Influenza Hemagglutinin Gene Insert

Overview
Journal Vaccine
Date 1999 Dec 11
PMID 10590330
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

A recombinant fowlpox vaccine with an H5 hemagglutinin gene insert protected chickens against clinical signs and death following challenge by nine different highly pathogenic H5 avian influenza viruses. The challenge viruses had 87.3 to 100% deduced hemagglutinin amino acid sequence similarity with the recombinant vaccine, and represented diversely geographic and spatial backgrounds; i.e. isolated from four different continents over a 38 year period. The recombinant vaccine reduced detectable infection rates and shedding titers by some challenge viruses. There was a significant positive correlation in hemagglutinin sequence similarity between challenge viruses and vaccine, and the ability to reduce titers of challenge virus isolated from the oropharynx (r(s)=0.783, P=0.009), but there was no similar correlation for reducing cloacal virus titers (r(s)=-0.100, P=0.78). This recombinant fowlpox-H5 avian influenza hemagglutinin vaccine can provide protection against a variety of different highly pathogenic H5 avian influenza viruses and frequent optimizing of the hemagglutinin insert to overcome genetic drift in the vaccine may not be necessary to provide adequate field protection.

Citing Articles

M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challenge.

Calzas C, Alkie T, Suderman M, Embury-Hyatt C, Khatri V, Le Goffic R NPJ Vaccines. 2024; 9(1):161.

PMID: 39237609 PMC: 11377767. DOI: 10.1038/s41541-024-00944-7.


Current Status of Poultry Recombinant Virus Vector Vaccine Development.

Wang H, Tian J, Zhao J, Zhao Y, Yang H, Zhang G Vaccines (Basel). 2024; 12(6).

PMID: 38932359 PMC: 11209050. DOI: 10.3390/vaccines12060630.


Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.

Sun Z, Wang Q, Li G, Li J, Chen S, Qin T Microbiol Spectr. 2021; 9(2):e0068721.

PMID: 34585985 PMC: 8557892. DOI: 10.1128/Spectrum.00687-21.


Discrepancies in the efficacy of H5 inactivated avian influenza vaccines in specific-pathogen-free chickens against challenge with the Egyptian H5N8 clade 2.3.4.4 Group B virus isolated in 2018.

El-Moeid A, El-Deeb A, Elsaied M, Soliman R, El-Safty M, Hussein H Vet World. 2021; 14(8):2131-2141.

PMID: 34566331 PMC: 8448630. DOI: 10.14202/vetworld.2021.2131-2141.


Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens.

Saikia D, Yadav K, Pathak D, Ramamurthy N, Dsilva A, Marriappan A Pathogens. 2019; 8(3).

PMID: 31510020 PMC: 6789743. DOI: 10.3390/pathogens8030145.